Serum Maresin-1 Predicts the Severity of Severe Acute Pancreatitis

Weiqin Li

Status: Unknown

Conditions: Pancreatitis, Acute

Study type: Observational

Funder types: Other

Identifiers

NCT03364920

SMPSSAP

Details and patient eligibility

About

This is a retrospective study about serum Maresin-1 level in different severe acute pancreatitis patients. The investigators want to study the correlation between the level of serum Maresin-1 and the severity of SAP, of course the clinical outcomes. The investigators want to find some biomarkers and strategy target drugs of severe acute pancreatitis.

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of Severe Acute Pancreatitis
• Biliary pancreatitis
• 7 days of the onset

Exclusion criteria

• Surgical patients
• Serious diseases and infection
• Alcoholic pancreatitis
• Hypertriglyceridemia pancreatitis
• Disorder of Glucolipide Metabolism：diabetes mellitus, hypertriglyceridemia, BMI>30

Trial design

200 participants in 2 patient groups

normal level of serum maresin-1

abnormal level of serum maresin-1